TY - JOUR
T1 - Short-term discontinuation of vagal nerve stimulation alters 18F-FDG blood pool activity: an exploratory interventional study in epilepsy patients
AU - Boswijk, Ellen
AU - Franssen, Renee
AU - Vijgen, Guy H. E. J.
AU - Wierts, Roel
AU - van Der Pol, Jochem A. J.
AU - Mingels, Alma M. A.
AU - Cornips, Erwin M. J.
AU - Majoie, Marian H. J. M.
AU - van Marken Lichtenbelt, Wouter D.
AU - Mottaghy, Felix M.
AU - Wildberger, Joachim E.
AU - Bucerius, Jan
N1 - Funding Information:
This study was financially supported in part by the Stichting de Weijerhorst (E.Bo., J.W., J.B.). W.D.v.M.L. was funded by EU FP7 project DIABAT (HEALTH-F2-2011-278373) and by the Dutch Organization for Scientific Research (NWO-ZonMw 91209037).
Publisher Copyright:
© 2019, The Author(s).
PY - 2019/12
Y1 - 2019/12
N2 - Background: Vagus nerve activation impacts inflammation. Therefore, we hypothesized that vagal nerve stimulation (VNS) influenced arterial wall inflammation as measured by
18F-FDG uptake. Results: Ten patients with left-sided VNS for refractory epilepsy were studied during stimulation (VNS-on) and in the hours after stimulation was switched off (VNS-off). In nine patients,
18F-FDG uptake was measured in the right carotid artery, aorta, bone marrow, spleen, and adipose tissue. Target-to-background ratios (TBRs) were calculated to normalize the respective standardized uptake values (SUVs) for venous blood pool activity. Median values are shown with interquartile range and compared using the Wilcoxon signed-rank test. Arterial SUVs tended to be higher during VNS-off than VNS-on [SUV
max all vessels 1.8 (1.5–2.2) vs. 1.7 (1.2–2.0), p = 0.051]. However, a larger difference was found for the venous blood pool at this time point, reaching statistical significance in the vena cava superior [
meanSUV
mean 1.3 (1.1–1.4) vs. 1.0 (0.8–1.1); p = 0.011], resulting in non-significant lower arterial TBRs during VNS-off than VNS-on. Differences in the remaining tissues were not significant. Insulin levels increased after VNS was switched off [55.0 pmol/L (45.9–96.8) vs. 48.1 pmol/L (36.9–61.8); p = 0.047]. The concurrent increase in glucose levels was not statistically significant [4.8 mmol/L (4.7–5.3) vs. 4.6 mmol/L (4.5–5.2); p = 0.075]. Conclusions: Short-term discontinuation of VNS did not show a consistent change in arterial wall
18F-FDG-uptake. However, VNS did alter insulin and
18F-FDG blood levels, possibly as a result of sympathetic activation.
AB - Background: Vagus nerve activation impacts inflammation. Therefore, we hypothesized that vagal nerve stimulation (VNS) influenced arterial wall inflammation as measured by
18F-FDG uptake. Results: Ten patients with left-sided VNS for refractory epilepsy were studied during stimulation (VNS-on) and in the hours after stimulation was switched off (VNS-off). In nine patients,
18F-FDG uptake was measured in the right carotid artery, aorta, bone marrow, spleen, and adipose tissue. Target-to-background ratios (TBRs) were calculated to normalize the respective standardized uptake values (SUVs) for venous blood pool activity. Median values are shown with interquartile range and compared using the Wilcoxon signed-rank test. Arterial SUVs tended to be higher during VNS-off than VNS-on [SUV
max all vessels 1.8 (1.5–2.2) vs. 1.7 (1.2–2.0), p = 0.051]. However, a larger difference was found for the venous blood pool at this time point, reaching statistical significance in the vena cava superior [
meanSUV
mean 1.3 (1.1–1.4) vs. 1.0 (0.8–1.1); p = 0.011], resulting in non-significant lower arterial TBRs during VNS-off than VNS-on. Differences in the remaining tissues were not significant. Insulin levels increased after VNS was switched off [55.0 pmol/L (45.9–96.8) vs. 48.1 pmol/L (36.9–61.8); p = 0.047]. The concurrent increase in glucose levels was not statistically significant [4.8 mmol/L (4.7–5.3) vs. 4.6 mmol/L (4.5–5.2); p = 0.075]. Conclusions: Short-term discontinuation of VNS did not show a consistent change in arterial wall
18F-FDG-uptake. However, VNS did alter insulin and
18F-FDG blood levels, possibly as a result of sympathetic activation.
KW - Vagal nerve stimulation (VNS)
KW - Inflammation
KW - Atherosclerosis
KW - Positron emission tomography (PET)
KW - Metabolism
KW - CHOLINERGIC ANTIINFLAMMATORY PATHWAY
KW - VAGUS NERVE
KW - GLUCOSE-UPTAKE
KW - HYPOTHALAMUS
KW - RISK
U2 - 10.1186/s13550-019-0567-9
DO - 10.1186/s13550-019-0567-9
M3 - Article
C2 - 31773320
SN - 2191-219X
VL - 9
JO - EJNMMI Research
JF - EJNMMI Research
IS - 1
M1 - 101
ER -